EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | N021937 | GILEAD SCIENCES LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Bristol-Myers Squibb & Gilead Sciences, LLC v. Lupin Ltd. 1 patentANDA 205590efavirenz, emtricitabine, tenofovir disoproxil fumarate (combination) | E.D. Tex. | 2014-07-24 | Terminated 2014-09-17 | — |
Gilead Sciences, Inc., et al v. Lupin Limited 2 patentsANDA 205590efavirenz, emtricitabine, tenofovir disoproxil fumarate | S.D.N.Y. | 2014-07-16 | Terminated 2014-09-17 | — |
Merck, Sharp & Dohme Corp. et al v. Teva Pharmaceuticals USA, Inc. et al 2 patentsANDA 091215efavirenz | S.D.N.Y. | 2010-03-09 | Terminated 2013-06-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).